Reliance Chemotex Industries Ltd has closed its trading window for dealing in the company's securities, effective from July 1, 2026. The restriction will remain in force until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This measure is implemented to ensure compliance with regulatory norms regarding insider trading during the period leading up to financial announcements.

The closure affects a broad group of individuals associated with the company, including directors, promoters, designated persons, and connected persons, along with their immediate relatives. This action is taken pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as well as the Company's Code of Prohibition of Insider Trading.

Compliance and Regulatory Framework

The decision to shut the trading window is a standard procedural step adopted by listed entities to prevent potential misuse of unpublished price-sensitive information (UPSI). By restricting trades during this sensitive period, the company aims to uphold market integrity and protect investor interests.

The intimation regarding the closure was formally addressed to BSE Limited and the National Stock Exchange of India Ltd. The communication was digitally signed by Chandrasekaran Rajagopalan, the CFO cum Company Secretary and Compliance Officer of Reliance Chemotex Industries Ltd.

Key Details of the Trading Window Closure

Reliance Chemotex Industries Ltd has approved an amended Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) to strengthen compliance with SEBI regulations. The board approved the updated code at its meeting held on May 29, 2026, pursuant to Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The amendment ensures that the company maintains uniformity, transparency, and fairness in its dealings with all stakeholders while preventing the misuse of sensitive information.

The revised code mandates that the company ensure prompt disclosure of UPSI to the stock exchanges where its securities are listed. It emphasizes that information must be universally disseminated to avoid selective disclosure, and once submitted to the exchange, the information is deemed generally available and no longer treated as UPSI. The Company Secretary & Compliance Officer serves as the Chief Investor Relation Officer responsible for the dissemination of information and handling UPSI disclosures.

Principles of Fair Disclosure

The code outlines specific principles to prevent insider trading and ensure market integrity. Key measures include:

• Prompt dissemination of any UPSI disclosed selectively or inadvertently.
• Providing fair responses to queries on news reports and market rumors from regulatory authorities.
• Ensuring information shared with analysts and research personnel is not UPSI.
• Maintaining transcripts or records of proceedings from analyst meetings on the official website.

The company is required to handle all UPSI on a "need to know" basis only. A structured digital database will be maintained to record details of individuals or entities with whom UPSI is shared for legitimate purposes, including their Permanent Account Number or other legal identifiers. This database will feature internal controls such as time stamping to prevent tampering.

Version Control

The following table details the approval history of the code:

The policy defines "legitimate purpose" for sharing UPSI as interactions with partners, collaborators, lenders, or advisors in the ordinary course of business, provided it is not intended to circumvent regulations. Any person receiving UPSI for a legitimate purpose is considered an "Insider" and must be bound by non-disclosure agreements outlining their duties and liabilities.